About PhenoTech

About company

PhenoTech a biotechnology company, engages in the discovery, development, and commercialization of reagents for diagnostic use in blood banks. The company offers blood diagnostic reagents, such as Nanoscale Emissive Antibody-complexes for Typing reagents for pre-transfusion testing. It also provides therapeutic agents, including a series of human-like monoclonal antibodies for treatment of Idiopathic Thrombocytopenic Purpura, an autoimmune disorder in the field of hematology; and anti-platelet agents, such as Infusable gpIIb/IIIa antagonist agents that are used after acute myocardial infarction, as well as in patients undergoing balloon angioplasty or stent placement in order to prevent cardiac ischemic complications.